Showing results (61-70 of 344) with videos related to
Sort By:
Pageof 35
Plos One|March 24, 2015
Dysregulated serum IL-23 and SIRT1 activity in peripheral blood mononuclear cells of patients with rheumatoid arthritisDaniel Wendling, Wasim Abbas, Marie Godfrin-Valnet, et al.Plos One|June 6, 2013
HLA-DRB1 genotypes and the risk of developing anti citrullinated protein antibody (ACPA) positive rheumatoid arthritisNathalie Balandraud, Christophe Picard, Denis Reviron, et al.Expert Opinion on Investigational Drugs|November 13, 2015
An overview of investigational new drugs for treating ankylosing spondylitisDaniel WendlingExpert Review of Clinical Immunology|April 24, 2015
Treating to target in axial spondyloarthritis: defining the target and the arrowDaniel WendlingBulletin De L'Academie Nationale De Medecine|June 8, 2018
Involvement of Th 17 pathway in spondyloarthritisDaniel WendlingJoint Bone Spine|June 20, 2019
Local sacroiliac injections in the treatment of spondyloarthritis. What is the evidence?Daniel WendlingExpert Opinion on Emerging Drugs|December 11, 2012
Are there new emerging drugs for ankylosing spondylitis or spondyloarthritis?Daniel WendlingExpert Opinion on Biological Therapy|November 23, 2023
Biological therapy in polymyalgia rheumaticaDaniel WendlingPageof 35